Honeywell Is Worth $35 Per Share More Than The Market Is Paying

Revenue growth by year, calendar 2021 through 2025: 3.2%, 3.2%, 3.4%, minus 5.4%, 7.8%. The FY2024 decline was the clearest sign of structural weakness. Management attributed it to specific programme deferrals and aerospace supply chain pressure; the Capital Desk reads it differently. The underlying issue was overweight exposure to late-cycle, pricing-sensitive segments that compressed as the rate cycle hit.

Operating margin moved from 17.4% in FY2021 to 15.4% in FY2025. That is a 200 basis point compression. Each point of margin on Honeywell's revenue base is worth roughly $370 million of operating profit. Management's stated 2027 target of 20% margins implies $1.7 billion of incremental operating profit. None of that is currently priced into the stock.

The diagnosis matters for whether the fix works. If the margin compression is cyclical, mean-reversion happens naturally as the cycle turns. If the compression is structural, reversion requires active portfolio reshaping. Honeywell's margin stack decomposition suggests the answer is structural; low-margin businesses grew their share of the mix while high-margin businesses stagnated. The Brady sale fits into that thesis as a small but meaningful vote for reshaping.

Honeywell announced the planned spin-off of Solstice Advanced Materials in early 2025, with completion expected later in calendar 2026. Solstice brings roughly $4 billion in revenue and produces specialty materials and fluorine products. The spin creates two purer-play businesses: remaining Honeywell focused on automation, aerospace, and sustainability solutions, and standalone Solstice operating as a materials pure-play.

On a sum-of-parts basis, remaining Honeywell should trade at 22-24x forward earnings given its aerospace and automation concentration (peer comps: Rockwell Automation at 27x, GE Aerospace at 32x). Solstice standalone should trade at 14-16x earnings given specialty chemicals peer comps (DuPont at 15x, Ashland at 13x). The blended valuation of the two businesses exceeds Honeywell's current 22x forward multiple by approximately 12-15%. That is the spin-off arbitrage.

The Capital Desk's internal model places standalone remaining Honeywell at roughly $215-230 per share equivalent and standalone Solstice at $55-65 per share equivalent. Total: $270-295. The stock trades at $227. There is meaningful slack in the current valuation, and the slack is tied to near-term visible catalysts rather than speculative future outcomes.

By comparison, GE's 2023 three-way split unlocked approximately 30% of incremental shareholder value from the pre-split aggregate. Honeywell's two-way split is a smaller deconglomeration, but the mechanics are similar. Structure changes; valuation follows.

The announced sale of a small industrial unit to Brady, disclosed in the quarterly filings, is not material to Honeywell's revenue line in any given year. The unit generates an estimated $200-300 million in annual revenue. What makes the transaction useful as a datapoint is what it signals about management's willingness to part with operationally profitable but strategically tangential businesses. Brady, a $3.8 billion enterprise value industrial labelling and safety products company, is a natural home for the business Honeywell is divesting. The logical strategic fit suggests a clean sale process, not a distress sale.

Management has flagged that roughly $3-4 billion of additional small and mid-sized divestments are under consideration through 2027. If executed, the cumulative portfolio prune plus the Solstice spin removes approximately $7-8 billion of non-core revenue. The reshape is substantive. The execution rhythm is what the Capital Desk is tracking; the Brady transaction suggests the rhythm is on schedule.

Historically, industrial conglomerates that execute disciplined portfolio reshaping across two to three years tend to re-rate meaningfully by year three. The last analogous case was Emerson Electric's 2021-2023 portfolio reshape, which included the Copeland separation and several smaller divestments. Emerson's forward P/E expanded from 14x to 23x across that window while the sector compressed by one point. The pattern is available to Honeywell if execution holds.

Honeywell Aerospace generates roughly $15 billion in annual revenue and is the single most valuable segment inside the current corporate structure. Aerospace operating margins sit in the mid-20s and the commercial aftermarket exposure is significant. At peer multiples, this segment alone would trade at 30-32x forward earnings. Inside the conglomerate, the market is not paying that multiple because the slower-growing industrial segments dilute the consolidated valuation narrative.

Post-spin Honeywell will have Aerospace as its largest and most valuable segment. That changes the valuation conversation. Sell-side models will rebuild their implied sum-of-parts on the new structure and the aerospace contribution will be more visible. This is the specific mechanism by which disaggregation unlocks value. The underlying assets do not change; the market's ability to price them does.

The Capital Desk prefers this dynamic over hopeful growth stories. Structural catalysts based on visible corporate actions are more reliable than hopeful catalysts based on product innovation or market share gains. Investor attention will concentrate as the spin date approaches. Historically, spin-off candidates have outperformed in the six months ahead of the official separation date; we are in that window now.

The cleanest peer for post-spin Honeywell is Emerson Electric, which completed its own reshape two years ago. Emerson trades at 23x forward earnings, post-reshape Honeywell is a marginally higher-quality business with stronger aerospace exposure, and the multiples should be within a half-point of each other at steady state. That points to 23-24x forward earnings for remaining Honeywell, implying $230-245 per share equivalent on current consensus numbers.

The industrial conglomerate peer set has compressed from five active peers a decade ago to effectively two today: Honeywell and 3M. 3M trades at 16x forward earnings with legal overhangs and flat revenue. Honeywell's 22x multiple reflects the market's awareness that the two are fundamentally different businesses. Post-spin, Honeywell leaves the conglomerate category entirely and joins the automation and aerospace cohort. The valuation should move accordingly.

Standalone Solstice is harder to value. Specialty fluorine products are a niche chemicals category with limited publicly traded comparables. Our working model uses a 13-15x forward earnings range based on adjacent specialty chemicals peers. That range is wide enough to accommodate meaningful uncertainty. If Solstice trades at the low end of the range, the sum-of-parts thesis softens slightly. If it trades at the high end, it strengthens materially. The asymmetry favours the bull case.

Across the last three major industrial deconglomeration programmes, the pattern is consistent. Tyco International's 2007 split produced 18% annualised returns across the subsequent five years for the combined post-split entities. ITT Corporation's 2011 three-way split delivered 14% annualised returns. GE's 2023 split is still evolving but aggregate returns to shareholders holding the three successor companies have been above 25% to date.

The common ingredient is not the quality of the underlying businesses. Tyco was mediocre before the split. ITT was decent. GE was in transition. The common ingredient is that fragmented investor bases, each with narrower mandates, price the standalone entities more accurately than a single conglomerate audience prices the aggregate. Passive flows also reshuffle as the new tickers enter different sector indices. Both dynamics support re-rating in the twelve months following separation.

Honeywell is the next in this sequence. The governance quality is higher than the historical precedents, which argues for cleaner execution. The starting margin position is better than GE's, which argues for faster proof points. The aerospace concentration in remaining Honeywell is higher than prior splits, which argues for a higher sustainable multiple. Every variable we can measure points in the same direction. The only material uncertainty is timing.

The reshape argument depends on management executing three specific workstreams in parallel. First, the Solstice spin has to close on schedule (targeting Q4 2026). Second, the operating margin recovery has to show visible progress in FY2026 results. Third, incremental small-scale divestitures have to continue at the current cadence of one to two per quarter.

All three are currently on track. The Brady transaction, announced this week, is evidence of the third workstream continuing. Preliminary Q1 2026 commentary from management suggested operating margin recovery was pacing ahead of schedule; the formal print is due in two weeks. The Solstice regulatory approvals are moving through normal review.

Any one of the three slipping does not invalidate the thesis but compresses the near-term catalyst window. All three slipping would require a meaningful rewrite. The Capital Desk's base case assumes on-schedule execution on all three. Current sell-side consensus implicitly assumes the same. The shared assumption means the downside on any slippage would be proportionally larger than the upside on any beat. Position sizing should reflect that asymmetry.

Honeywell generated $5.4 billion of free cash flow in FY2025, up modestly from $4.9 billion in FY2024. The capital return programme has been disciplined: roughly $3.5 billion in buybacks and $2.9 billion in dividends annually. Total debt stands at $27 billion against $12 billion of cash, producing a net leverage ratio of 1.5x EBITDA. Balance sheet flexibility is high.

The question is whether Honeywell deploys that flexibility into further M&A or into higher capital return while the spin-off moves through close. Management has signalled the latter through 2026, with M&A capacity reserved for post-spin deployment. The Capital Desk views this as the correct sequence. Acquiring during a planned structural separation is usually the wrong move; investors typically discount the acquiring entity's capital allocation discipline when two complex corporate actions happen in parallel.

Forward P/E of 22.1x looks optically expensive against the sector at 19x. But if the margin target of 20% is hit by FY2027, the current stock trades at 18x forward earnings on that basis. That is a modest premium to peers for a higher-quality, post-reshape business. The valuation work supports the thesis.